Hemosol B0

Calcium, Lactic Acid, Magnesium, Sodium, Chloride Ion, Hydrogen Carbonate, the active ingredient in Hemosol B0, is an electrolyte solution presented as a solution for injection for haemodialysis and intravenous use. It corrects electrolyte and acid‑base imbalances during haemodialysis and provides fluid replacement in patients requiring intravenous therapy.

GNH USA supplies Hemosol B0 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and dialysis clinics worldwide.

Hemosol B0, an electrolyte solution used in renal replacement therapy, is indicated for: - Hemodialysis: restores electrolyte balance and corrects acid‑base disturbances during treatment. - Intravenous fluid replacement: provides essential electrolytes and volume support in patients with fluid loss. - Electrolyte balance correction: corrects deficiencies of calcium, magnesium, sodium, chloride and bicarbonate in various clinical settings.

Common Side Effects: - Mild hypercalcemia: transient elevation of serum calcium. - Transient hypotension: slight drop in blood pressure during infusion. - Local irritation at infusion site: redness or discomfort. - Nausea: occasional feeling of queasiness. - Headache: mild to moderate.

Serious or Rare Side Effects: - Severe hypermagnesemia: high magnesium levels causing cardiac effects. - Metabolic alkalosis: excessive bicarbonate leading to elevated pH. - Anaphylactic reaction: rare severe allergic response. - Electrolyte overload: risk of arrhythmia due to excess ions.

Before initiating therapy, evaluate the patient’s baseline electrolyte and acid‑base status. - Assess electrolyte levels: check serum calcium, magnesium, sodium and bicarbonate. - Monitor during infusion: frequent laboratory checks to avoid overload. - Adjust rate in cardiac disease: slower infusion for patients with heart failure. - Use caution in renal impairment: reduced clearance may increase risk. - Store at ambient temperature: keep in original container, protect from light and moisture.

Major Interactions (Avoid): - Calcium‑containing antacids: may cause hypercalcemia. - Magnesium sulfate infusion: risk of hypermagnesemia. - Sodium bicarbonate infusion: may lead to electrolyte overload.

Moderate Interactions (Monitor Closely): - Loop diuretics: can alter electrolyte balance. - ACE inhibitors: may affect potassium and overall electrolyte status. - Blood transfusions: can influence calcium levels.